KDM1A and cancer: Another strategy involves dual inhibition of both histone deacetylases (HDAC) and KDM1A with 4SC-202 which targets HDAC1, 2, 3, and KDM1A and has been shown to inhibit the stem-related properties of cancer cells reducing their viability (Henning et al., 2010).